LRP1: a novel receptor for the transmission of pathological α-Synuclein

Mol Neurodegener. 2022 Nov 26;17(1):79. doi: 10.1186/s13024-022-00582-4.
No abstract available

Keywords: LRP1; Parkinson’s disease; Receptor mediated endocytosis; α-Synuclein.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, N.I.H., Extramural

MeSH terms

  • Neurons*
  • alpha-Synuclein*

Substances

  • alpha-Synuclein